Related Experiment Video
Updated: Sep 19, 2025

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Malaria: past, present, and future.
Qilong Li1,2, Tong Liu1,2, Kunying Lv1,2
1Key Laboratory of Livestock Infectious Diseases, Ministry of Education, and Key Laboratory of Ruminant Infectious Disease Prevention and Control (East), Ministry of Agriculture and Rural Affairs, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang, China.
Malaria remains a major global health threat, with increasing cases and deaths despite prevention efforts. This review details recent advances in understanding Plasmodium parasites and developing new treatments to combat drug resistance.
Area of Science:
- * Malariology and Parasitology
- * Infectious Diseases and Public Health
- * Drug Discovery and Development
Background:
- * Malaria, caused by Plasmodium parasites transmitted by Anopheles mosquitoes, significantly impacts global health and economies, especially in sub-Saharan Africa.
- * Despite progress, clinical cases and mortality are rising due to parasite genetic diversity and emerging artemisinin resistance.
- * Recent biotechnological advancements have greatly improved understanding of parasite biology, pathogenicity, and host-parasite interactions.
Purpose of the Study:
- * To review recent research progress in Plasmodium biology and pathogenesis, focusing on Plasmodium falciparum.
- * To summarize therapeutic targets and clinical applications of current anti-malarial drugs, including FDA-approved regimens.
- * To explore novel drug and vaccine development strategies to overcome parasite resistance.
Main Methods:
- * Comprehensive literature review of recent scientific publications on malaria research.
- * Analysis of Plasmodium falciparum biology, pathogenesis, and host-parasite interactions.
- * Evaluation of current and emerging anti-malarial therapies, including drug resistance patterns.
Main Results:
- * Significant advancements in understanding Plasmodium biology and pathogenesis driven by modern biotechnology.
- * Review of FDA-approved anti-malarial drugs (Artemether-Lumefantrine, Atovaquone-Proguanil, Primaquine) highlighting benefits, limitations, and resistance issues.
- * Identification of promising novel drug candidates (Sevuparin, Imatinib, Cipargamin) and combination therapies for overcoming resistance.
Conclusions:
- * Continued innovation in malaria treatment and prevention is crucial to combat rising cases and drug resistance.
- * Further research into Plasmodium biology and host-parasite interactions is essential for developing effective interventions.
- * Development of novel vaccines and combination therapies holds promise for overcoming current treatment challenges.
More Related Videos
Related Concept Videos
Symbiosis
Diversity of Protists II
Overview of Protists

